Literature DB >> 6142383

Carnitine deficiency: a possible mechanism for valproate hepatotoxicity.

D L Coulter.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6142383     DOI： 10.1016/s0140-6736(84)92209-8

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  13 in total

1.  Case files of the Children's Hospital of Michigan Regional Poison Control Center: the use of carnitine for the management of acute valproic acid toxicity.

Authors:  Abhishek Katiyar; Cynthia Aaron
Journal:  J Med Toxicol       Date:  2007-09

2.  Features of Adult Hyperammonemia Not Due to Liver Failure in the ICU.

Authors:  Amra Sakusic; Moldovan Sabov; Amanda J McCambridge; Alejandro A Rabinstein; Tarun D Singh; Kumar Mukesh; Kianoush B Kashani; David Cook; Ognjen Gajic
Journal:  Crit Care Med       Date:  2018-09       Impact factor: 7.598

3.  Efficacy and Safety of Valproic Acid for Spinal Muscular Atrophy: A Systematic Review and Meta-Analysis.

Authors:  Abdelrahman Elshafay; Truong Hong Hieu; Mohamed Fahmy Doheim; Mahmoud Attia Mohamed Kassem; Mohammed Fathi ELdoadoa; Sarah Keturah Holloway; Heba Abo-Elghar; Kenji Hirayama; Nguyen Tien Huy
Journal:  CNS Drugs       Date:  2019-03       Impact factor: 5.749

4.  Heterozygotes for plasmalemmal carnitine transporter defect are at increased risk for valproic acid-associated impairment of carnitine uptake in cultured human skin fibroblasts.

Authors:  I Tein; S DiMauro; Z W Xie; D C De Vivo
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

Review 5.  Valproate-associated hepatotoxicity and its biochemical mechanisms.

Authors:  M J Eadie; W D Hooper; R G Dickinson
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 Mar-Apr

6.  Short-term effects of administration of anticonvulsant drugs on free carnitine and acylcarnitine in mouse serum and tissues.

Authors:  M F Camiña; I Rozas; M Gómez; J M Paz; C Alonso; S Rodriguez-Segade
Journal:  Br J Pharmacol       Date:  1991-05       Impact factor: 8.739

Review 7.  Clinical pharmacokinetics of valproic acid--1988.

Authors:  G Zaccara; A Messori; F Moroni
Journal:  Clin Pharmacokinet       Date:  1988-12       Impact factor: 6.447

Review 8.  Valproate hepatotoxicity syndrome: hypotheses of pathogenesis.

Authors:  J R Stephens; R H Levy
Journal:  Pharm Weekbl Sci       Date:  1992-06-19

Review 9.  Science review: carnitine in the treatment of valproic acid-induced toxicity - what is the evidence?

Authors:  Philippe E R Lheureux; Andrea Penaloza; Soheil Zahir; Mireille Gris
Journal:  Crit Care       Date:  2005-06-10       Impact factor: 9.097

10.  Phase II open label study of valproic acid in spinal muscular atrophy.

Authors:  Kathryn J Swoboda; Charles B Scott; Sandra P Reyna; Thomas W Prior; Bernard LaSalle; Susan L Sorenson; Janine Wood; Gyula Acsadi; Thomas O Crawford; John T Kissel; Kristin J Krosschell; Guy D'Anjou; Mark B Bromberg; Mary K Schroth; Gary M Chan; Bakri Elsheikh; Louise R Simard
Journal:  PLoS One       Date:  2009-05-14       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.